CYTOKINE-INDUCIBLE NITRIC-OXIDE SYNTHASE (INOS) EXPRESSION IN CARDIACMYOCYTES - CHARACTERIZATION AND REGULATION OF INOS EXPRESSION AND DETECTION OF INOS ACTIVITY IN SINGLE CARDIAC MYOCYTES IN-VITRO
Jl. Balligand et al., CYTOKINE-INDUCIBLE NITRIC-OXIDE SYNTHASE (INOS) EXPRESSION IN CARDIACMYOCYTES - CHARACTERIZATION AND REGULATION OF INOS EXPRESSION AND DETECTION OF INOS ACTIVITY IN SINGLE CARDIAC MYOCYTES IN-VITRO, The Journal of biological chemistry, 269(44), 1994, pp. 27580-27588
Cellular constituents of heart muscle contain both constitutive and in
ducible nitric oxide (NO) signaling pathways that modulate the contrac
tile properties of cardiac myocytes. The identities of the inducible N
O synthase (iNOS) isoform(s) expressed in cardiac muscle, and of the s
pecific cell types expressing iNOS activity, remain poorly characteriz
ed. We amplified a 217-base pair cDNA by reverse transcriptase-polymer
ase chain reaction from primary cultures of inflammatory cytokine pret
reated adult rat ventricular myocytes (ARVM) that was nearly identical
to other NOS cDNA sequences. Using this 217-base pair cDNA as a probe
in Northern blots, we found no evidence of iNOS mRNA in control myocy
tes, but both interleukin-1 beta and interferon-gamma individually inc
reased MOS mRNA abundance in primary cultures of ARVM, with maximal ex
pression at 12 h. The half life of iNOS mRNA in actinomycin C1-treated
cells was 4 h. Both dexamethasone and transforming growth factor-beta
attenuated the induction of iNOS mRNA abundance and enzyme activity b
y IL-1 beta and INF gamma. Pretreatment with dexamethasone also abolis
hed the induction of iNOS mRNA, but not the increase in GTP cyclohydro
lase mRNA in purified cardiac myocytes from lipopolysaccharide-injecte
d rats, In order to further characterize the specific cell type produc
ing NO, we used a NO-specific porphyrinic/Nafion-coated microsensor to
record NO release from a single, isolated ARVM pretreated with IL-1 b
eta and IFN gamma in L-arginine-depleted medium. NO release could be d
etected following microinjection of L-arginine in the vicinity of the
cell juxtaposed to the NO microsensor, but not following microinjectio
n of D-arginine, and not from ARVM pretreated with L-N-monomethylargin
ine. Cytokine-pretreated ARVM that had been maintained in L-arginine-d
epleted medium also exhibited a depressed contractile response to isop
roterenol after addition of L-arginine, but not D-arginine. These resu
lts indicate that altered contractile function of cardiac myocytes fol
lowing exposure to specific inflammatory cytokines is due to induction
of myocyte iNOS.